Home
Technology Platforms
Harbour Mice
®
Single Cell Technology Platform
HBICE
®
Fully Human Generative AI HCAb Model
Therapeutics
Inflammatory & Immunology Diseases
Oncology/Immuno-Oncology
Weight Management
Publications
Harbour Medical
Overview
Clinical Development & Medical Services
Scientific Committee
IND-IIT Bidirectional Drive Model
AI-Empowered Full Clinical Trial Lifecycle
An Efficient and Collaborative Organizational System
Partnership
Technology Service
Technology License
Asset License
Co-development
Strategic Collaboration
Cooperation Contact
About Us
Company Overview
Corporate Strategy
Management Team
Scientific Advisory Board
Our History
Our Locations
Newsroom
Investor Relations
Corporate Governance
Stock Information
Disclosure
Financials
Presentations and Events
Analyst Coverage
Notices-Replacement of Lost Share Certificates
Subscribe to Updates
Careers
中国 — 简体中文
Global — English
Home
Technology Platforms
BACK
Technology Platforms
Harbour Mice
®
Single Cell Technology Platform
HBICE
®
Fully Human Generative AI HCAb Model
Therapeutics
BACK
Therapeutics
Inflammatory & Immunology Diseases
Oncology/Immuno-Oncology
Weight Management
Publications
Harbour Medical
BACK
Harbour Medical
Overview
Clinical Development & Medical Services
Scientific Committee
IND-IIT Bidirectional Drive Model
AI-Empowered Full Clinical Trial Lifecycle
An Efficient and Collaborative Organizational System
Partnership
BACK
Partnership
Technology Service
Technology License
Asset License
Co-development
Strategic Collaboration
Cooperation Contact
About Us
BACK
About Us
Company Overview
Corporate Strategy
Management Team
Scientific Advisory Board
Our History
Our Locations
Newsroom
Investor Relations
BACK
Investor Relations
Corporate Governance
Stock Information
Disclosure
Financials
Presentations and Events
Analyst Coverage
Notices-Replacement of Lost Share Certificates
Subscribe to Updates
Careers
Investor Relations
Effective Communication Drives Development
Corporate Governance
Stock Information
Disclosure
Financials
Presentations and Events
Analyst Coverage
Notices-Replacement of Lost Share Certificates
Subscribe to Updates
Home
>
Investor Relations
>
Disclosure
Disclosure
Listing Documents
Financial Report/ESG information
Announcement & Notice
IR Journal
2024-07-04
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
2024-06-27
INSIDE INFORMATION - UPDATE ON THE DEVELOPMENT FOR BATOCLIMAB (HBM9161)
2024-06-21
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
2024-06-21
RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND CHANGES IN COMPOSITION OF BOARD COMMITTEES
2024-06-13
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
2024-06-13
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
2024-06-06
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 6 JUNE 2024
2024-06-06
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
2024-05-23
INSIDE INFORMATION - ENTERING INTO LICENSE AND OPTION AGREEMENT WITH ASTRAZENECA FOR NOVEL TUMOR TARGETED THERAPIES
2024-05-08
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
2024-04-30
Next Day Disclosure Return
2024-04-27
NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF 2023 ANNUAL REPORT, CIRCULAR, PROXY FORM AND NOTICE OF AGM
2024-04-25
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING
2024-04-25
NOTICE OF ANNUAL GENERAL MEETING
2024-04-25
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; RE-ELECTION OF RETIRING DIRECTORS; AND NOTICE OF ANNUAL GENERAL MEETING
2024-04-19
Next Day Disclosure Return
2024-04-17
VOLUNTARY ANNOUNCEMENT - VOLUNTARY LOCK-UP UNDERTAKING BY EXECUTIVE DIRECTOR
2024-04-09
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
2024-04-04
GRANT OF SHARE OPTIONS AND GRANT OF SHARE AWARDS
2024-04-02
Next Day Disclosure Return
1
···
11
12
···
21
Jump